Description

Meditoxin 200: Classic Safety Profile and Maximum Profitability

Meditoxin 200 is a time-tested botulinum toxin type A from the leading South Korean company Medytox, available in an extended dosage. Featuring a classic molecular weight of 900 kDa, the product has an action profile and diffusion rate identical to the original benchmark Botox. The 200-unit vial is the optimal and cost-effective choice for clinics with high patient volume, as well as for comprehensive “full face” rejuvenation protocols and full-scale localized hyperhidrosis therapy.

Key Benefits Meditoxin 200:

Cost-Effectiveness: The larger vial significantly reduces the cost per unit, optimizing expenses when treating large areas or performing complex protocols.

Targeted Precision: The classic molecular structure (900 kDa) strictly limits diffusion, allowing for highly targeted injections without the risk of asymmetry.

Proven Efficacy: One of the most studied and popular neurotoxins, backed by years of safe clinical use worldwide.

Stable Results: Demonstrates a rapid onset of action and maintains a stable muscle relaxation effect for up to 5–6 months.

Indications:

Comprehensive treatment of localized hyperhidrosis (axillae, palms, soles).

“Full face” dynamic wrinkle correction.

Correction of hypertonicity in larger muscles (platysmal bands, masseter muscle for bruxism).

Body botulinum therapy (e.g., trapezius muscle contouring).

Specifications:

Active Ingredient: Botulinum Toxin Type A (200 Units).

Form: Lyophilized powder (1 vial).

Manufacturer: Medytox (South Korea).